Currently located in the Sandia Electro-Optics Corporation (SE-OC) incubator, ETA Diagnostics, Inc. (ETAD) spun off from Sabdia Electro-Optics as an independent C-Corporation. ETADs mission is to commercialize the massively parallel flow cytometry technology invented at the University of New Mexicos Center for Biomedical Engineering.is organized around development and commercialization of the high throughput massively parallel flow cytometry technology invented by faculty at the University of New Mexicos Center for Biomedical Engineering (UNM/CBME). The Companys disruptive technology holds promise in a variety of life science applications, including the detection and analysis of Circulating Tumor Cells (CTCs). ETAD is has an exclusive intellectual property licensing agreement with UNMs Science and Technology Corporation (STC.UNM) that covers ETADs four US patents (2 patents issued, 2 patents pending)
